Dr. Minerowicz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
310 Cedar St
New Haven, CT 06510Phone+1 203-384-3156
Education & Training
UPMC Medical Education/Presbyterian Shadyside HospitalFellowship, Thoracic Pathology, 2016 - 2017
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Pathology-Anatomic and Clinical, 2011 - 2015
Naval Medical Center (Portsmouth)Internship, Transitional Year, 2007 - 2008
Rutgers Robert Wood Johnson Medical SchoolClass of 2007
Certifications & Licensure
CT State Medical License 2020 - 2025
NJ State Medical License 2016 - 2025
VA State Medical License 2008 - 2024- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- 13 citationsNovel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer.Jenna H. Newman, David Augeri, Rachel NeMoyer, Jyoti Malhotra, Elaine Langenfeld
Oncogene. 2018-04-06 - 4 citationsExpression of PD-L1 in Patients With Malignant Peritoneal Mesothelioma: A Pilot Study.Victor P Gazivoda, Aaron W Kangas-Dick, Alissa A Greenbaum, Joshua Roshal, Chunxia Chen
The Journal of Surgical Research. 2022-09-01 - 2 citationsSomatic Mutation of BAP1 Can Lead to Expression Loss in Non-Small Cell Lung Carcinoma: Next Generation Sequencing and IHC Analysis in A Large Single Institute Cohort.Tong Sun, Xi Wang, Minhua Wang, Christine Minerowicz, Harold Sanchez
International Journal of Surgical Pathology. 2022-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
